pentobarbital will lower the level or outcome of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers can lead to diminished serum concentrations and lack of antimalarial efficacypentobarbital will lessen the e